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Background: Primary informal caregivers provide a substantial amount of the care and support for persons with
Alzheimer’s disease (AD). This review aims to investigate the association between the quality of life (QoL) of primary
informal AD caregivers and the level of care that these caregivers provide to persons with AD.
Methods: Studies involving primary informal caregivers of persons with AD will be included in the review. These
studies will be required to focus on the care that caregivers provide for their loved ones. The primary outcome is
level or quality of care. The main independent variable is caregiver QoL. In addition to QoL, we will include studies
that examine other independent variables that are considered to be important components of QoL. These variables
include social support, caregiver burden, caregiver wellbeing, and caregiver depression.
We will search Medline-OVID, Embase-OVID, Cochrane Central-OVID, and PsycINFO-OVID from inception onwards.
Two raters will independently screen each article using pre-established inclusion/exclusion criteria. Screening will
take place at two levels: title and abstract, and full text. Conflicts will be resolved by discussion or by a third
reviewer. We will assess the risk of bias of each included study using standardized quality assessment tools for
specific types of designs. A narrative synthesis method will be used to describe our findings. Quantitative summary
and meta-analysis will be conducted if appropriate. We will employ GRADE to evaluate the strength of the
evidence in this review.
Discussion: Results of this systematic review will show whether and how caregiver QoL is related to the level of
care that caregivers provide to persons with AD.
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Alzheimer’s disease (AD) is a neurodegenerative disorder
characterized by progressive declines in cognitive and
functional abilities. Symptoms often begin with memory
loss and progress to an inability to perform basic activities
of daily living (for example, bathing and eating) [1]. The
estimated prevalence of AD in the Canadian population
aged 65 years or over is 300,000 persons [2]. Approxi-
mately 40,000 Canadians develop the disease annually [3].
Projections suggest the total number of Canadians with
AD could rise to 509,000 in 2031 [3,4]. In the United* Correspondence: hazzanaa@mcmaster.ca
1Department of Clinical Epidemiology and Biostatistics, McMaster University,
Hamilton, ON, Canada
Full list of author information is available at the end of the article
© 2013 Hazzan et al.; licensee BioMed Central
Commons Attribution License (http://creativec
reproduction in any medium, provided the orStates, an estimated 5.4 million people have AD in 2012,
including 5.2 million people age 65 and older [5]. About
35 million people worldwide had AD in 2010 and this fig-
ure has been projected to top 115 million by 2050 [6].
There will be a 63% increase in the proportion of people
living with dementia in North America over the next 20
years [6].
Primary informal caregivers provide a substantial amount
of the care and support required for persons with AD.
These caregivers are usually close relatives (for example,
spouses, children) of their ‘loved ones’ with AD and they
are generally unpaid for the care they provide. As AD pro-
gresses, caregivers watch their loved ones deteriorate at the
same time as they are called upon to perform an increasing
range of tasks that ultimately include helping loved onesLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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quality of life (QoL) experienced by unpaid family care-
givers in AD has been shown to be lower than the QoL of
caregivers for persons who do not have AD [7]. Among
carers of people with chronic conditions in general, caring
for a person with AD is particularly stressful, and these
caregivers have been called the ‘hidden victims’ of the dis-
ease [6,8]. The strain of performing caregiver tasks, coupled
with emotional stress and a sense of being ‘trapped’ in the
caregiving role, are among the leading reasons caregivers
cite for institutionalizing their loved ones [9].
Research has shown that lower QoL can increase ab-
sences from work and reduce job productivity [10]. In the
domain of care provision, it is possible that these work-
place productivity issues might translate into declining
‘caregiver productivity’. Therefore, this review aims to in-
vestigate the association between the QoL of primary in-
formal AD caregivers and the level of care that these
caregivers provide to persons with AD. This review will
address two research questions:
1. What is the relationship between caregiver QoL and
level of care?
2. What is the relationship between caregiver QoL and
quality of care?
Level of care includes caregiver willingness to provide
care and the amount of time spent providing care. Quality
of care will be operationalized using any means (caregiver
mastery, task management strategy, and so on) that have
been designed to measure this concept [11].
In addition to QoL, we will include studies examining
related concepts such as social support, caregiver burden,
wellbeing, and caregiver depression. These concepts are
closely related to QoL and could provide valuable insight
into the relationship between QoL and level of care.
Methods
The systematic review described in this protocol follows
the PRISMA statement [12].
Information sources and literature search
The following electronic databases will be searched
from start date to 2012: Medline-OVID, Embase-OVID,
Cochrane Central-OVID, and PsycINFO-OVID. Inter-
net searches for gray literature will also be performed.
General search terms for electronic databases
The following terms will be used when devising search
strategies for electronic databases:
1. *Alzheimer Disease/
2. Family Nursing/
3. 1 and 24. (family adj2 caregiv*).ti.
5. 1 and 4
6. *Caregivers/
7. 1 and 6
8. ((informal or family or spous*) adj3 (care* or
caregiv*)).tw.
9. 7 and 8
10. 3 or 5 or 9
11. Alzheime*.ti.
12. ((informal or family or spous*) and (care* or
caregiv*)).ti.
13. 11 and 12
14. 9 or 13
15. limit 14 to (biography or comment or editorial or
in vitro or letter)
16. 14 not 15
The search strings above will be adjusted for each data-
base. An experienced librarian will conduct the literature
search in all four databases. Results from the literature
search will be uploaded to DistillerSR (Evidence Partners
Incorporated, Ottawa, Canada; Copyright 2010), an online
application that will be used for the screening and data ex-
traction phases of this systematic review.Eligibility criteria
We will include studies dealing with primary informal
caregivers of community-dwelling persons with AD. These
unpaid caregivers are typically close relatives (for example,
spouses, children) who provide the bulk of care and sup-
port. Studies including only paid caregivers, such as home
help aides or employees of long-term care facilities, as well
as studies set only in institutions, will be excluded from
the review. There will be no restrictions on the sex, age, or
ethnic background of caregivers.
Included studies must report at least one of the follow-
ing outcomes in relation to caregiver QoL: level of care,
quality of care, amount of time spent providing care,
and similar variables dealing with caregiver performance
in their caregiving role. We will include primary studies
that provide quantitative results. We will include studies
written in any language that are experimental (including
RCTs, quasi-randomized trials, controlled clinical trials),
quasi-experimental (including interrupted time series
and controlled before and after studies), or observational
designs with comparison groups.Level or quality of care
Due to the difficulty involved in determining what con-
stitutes ‘quality’ care, studies using any scale that was
designed to measure quality will be considered for inclu-
sion. This includes studies measuring ‘level’ or ‘quality’
of care from a task-oriented perspective.
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The concept of QoL is multi-faceted and may be defined
in several ways. In this review, QoL will be treated as an in-
dependent variable. The most common approach to meas-
uring QoL involves the use of scales, several of which have
been developed for healthcare research [13]. Popular, gen-
eric, health-related QoL scales include the Short Form 36
(SF-36) [14], EuroQoL Group’s EQ-5D [15], and the World
Health Organization Quality of Life-BREF (WHOQOL-
BREF) [16]. Other QoL scales, such as the Quality-of-life -
Alzheimer’s Disease (QOL-AD) scale [17], were specifically
developed for use in patient populations or diseases.
We will include any study measuring QoL, regardless
of the specific scale used. In addition to QoL, studies
examining the impact of the following constructs on our
outcomes will be included.
Social support
Social support is a multidimensional construct of the
extent to which individuals receive emotional support,
instrumental assistance, information, guidance and feed-
back, personal appraisal support, and companionship from
family members, friends, co-workers, other persons (for
example, acquaintances, religious leaders, therapists), or
organizations (for example, caregiver support groups).
Caregiver burden
Caregiver burden is operationalized by any construct
representing the physical, emotional, and financial cost
of providing care for a loved one with AD. The Zarit
Burden Interview (ZBI) [8,18] is a widely used instru-
ment for measuring caregiver burden.
Caregiver depression
Although depression is an element of QoL, it is also an
important construct on its own. Indeed, depression is one
of the common side effects of long-term caregiving [19].
Depression can be measured by several instruments in-
cluding the Center for Epidemiologic Studies-Depression
(CES-D) scale [20,21].
We will include any study measuring these constructs,
regardless of the means by which these constructs are
measured.
Included studies may present quantitative results only.
Selection procedure
Two reviewers will independently screen the titles and
abstracts of studies identified in the literature search.
Studies meeting the eligibility criteria, or studies whose
titles and abstracts do not provide sufficient information
to assess eligibility, will advance to full-text screening.
During full-text screening, the reviewers will independ-
ently read entire papers and assess eligibility. Conflictswill be resolved by discussion between the two reviewers
or by the involvement of a third reviewer.
Data collection process
A detailed data collection form will be developed to collect
information about study characteristics (study design,
sample size, year, country), participant characteristics (for
example, type and number of patients, caregiver relation-
ship to person with AD, living situation, age, mean and
standard deviation, AD diagnosis criteria), and results (for
example, quality of life, quality of care, institutionalization,
amount of care, and so on).
Data will be extracted using an online form uploaded to
DistillerSR. The data extraction form will be piloted by
two reviewers and further refined if necessary. Two re-
viewers will independently extract all of the data to
achieve the highest level of accuracy. Reviewers will meet
to resolve discrepancies. If the two reviewers cannot agree,
then a third reviewer will be asked to adjudicate.
In cases where studies report outcome results over dif-
ferent time periods, we will extract data from each time
period to examine the impact of the intervention over
time. Further, in cases where multiple publications re-
port data from the same study, we will use the most
current report of the outcomes of interest. When data
are not clearly reported, we will contact the lead author
of the study for clarification.
Assessment of risk of bias
Each included study will be assessed for risk of bias using
appropriate quality assessment tools. For studies employing
RCT design, we will use the Cochrane Risk of Bias Tool
[22]. The Cochrane Effective Practice and Organisation of
Care Risk of Bias Tool will be used for assessment of risk
of bias for controlled clinical trials, interrupted time series,
and controlled before-after studies [23,24]. Finally, the
Newcastle-Ottawa Scale will be used for studies employing
cohort and case control designs [25].
We will use GRADE to assess the level of evidence
across studies and also use funnel plots to assess publi-
cation bias [26].
Synthesis
A narrative synthesis method will be used to describe
the results. All included studies will be summarized in
narrative form, and summary tables will be created
showing key study characteristics (that is, population
characteristics, treatment interventions, study outcomes,
sample sizes, settings, funding sources, and comparator
treatments (type, duration, and provider)), methodo-
logical limitations, and any other important aspect re-
lated to each research question of interest.
Meta-analysis will be performed if possible from the
data extracted from the included studies. If clinical
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separate qualitative analysis will be presented and graph-
ical representation may be used to display main study
outcomes.
If outcomes of interest in each included study were
reported using different outcome measures on a continu-
ous scale, the DerSimonian and Laird random effects
models with inverse variance method will be utilized to
generate the summary measures of effect in the form of
standardized mean difference (SMD) for each outcome
[27]. The use of SMD as a summary statistic in a system-
atic review is appropriate if the same oucome (that is,
quality of care) is assessed in a variety of ways or if differ-
ent psychometric scales were used [27]. In such a situ-
ation, it would be necessary to standardize the results of
the studies before they could be compared across studies
or combined in a quantitative synthesis.
Standardized mean differences (SMDs) will be calcu-
lated using change from baseline data, that is, mean differ-
ence between pre-treatment (baseline) and post-treatment
(final/endpoint) scores along with its standard deviation
for both intervention and control groups. Appropriate
correlation between pre-treatment (baseline) and post-
treatment (final/endpoint) level of care scores will be used
based on evidence from existing literature. The Cochran’s
Q (α=0.10) and I2 statistic will be utilized to quantify the
statistical heterogeneity between studies examining our
outcomes of interest, where P <0.10 indicates a high level
of statistical heterogenity between these studies. Sensitivity
analyses will be performed on the type of intervention,
study risk of bias and by removing studies with obvious
between-group baseline imbalance in order to evaluate
statistical stability and effect on statistical heterogeneity.
Discussion
Results of this systematic review will show whether and
how caregiver QoL is related to the level of care that
caregivers provide to persons with AD. The results could
help caregivers, caregiver support organizations, and
policy-makers make informed decisions about programs
to optimize the care that persons with AD receive from
their caregivers.
We will publish results of this systematic review in a
peer-reviewed journal to make the results widely available
to researchers and policy-makers. We will also present our
results at relevant research meetings and make the find-
ings accessible to caregiver support organizations.
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